Efficacy of sirolimus on ischemic-type biliary lesions after liver transplantation
نویسندگان
چکیده
Objective: To explore and summarize the effect of sirolimus on ischemic-type biliary lesions (ITBL) after liver transplantation. Methods: A retrospective study was carried out on 52 patients using sirolimus for biliary complications after liver transplantation from 2004 to 2016 in our hospital. Serum alanine transaminase (ALT), aspartate transaminase (AST), total bilirubin, glutamyl endopeptidase, and alkaline phosphatase (ALP) after the surgery, and six months later were recorded and analyzed, the 1and 3-year graft survival rates were analyzed. Results: Serum alanine transaminase (ALT), aspartate transaminase (AST), total bilirubin, glutamyl endopeptidase, and alkaline phosphatase (ALP) significantly increased in 52 patients with ITBL. Among the patients with ITBL, 30 patients were treated with sirolimus after the surgery, and six months later, the above indices significantly improved in the treatment group compared with the control group. The patients in control group were treated by traditional plan, tacrolimus based treatment without sirolimus. The 1and 3-year graft survival rates in the sirolimus group were higher than those in the control group. Moreover, the second transplantation rate was lower in the treated group. The blood lipid level was higher in the sirolimus group compared with the control group. Conclusion: Sirolimus is clinically effective for management of ITBL. Until a better treatment is found, sirolimus is worth attempting, and secondary transplantation may be avoided.
منابع مشابه
Liver Preservation by Aortic Perfusion Alone Compared With Preservation by Aortic Perfusion and Additional Arterial Ex Situ Back-Table Perfusion With Histidine-Tryptophan-Ketoglutarate Solution: A Prospective, Randomized, Controlled, Multicenter Study
BACKGROUND Arterial ex situ back-table perfusion (BP) reportedly reduces ischemic-type biliary lesion after liver transplantation. We aimed to verify these findings in a prospective investigation. METHODS Our prospective, randomized, controlled, multicenter study involved livers retrieved from patients in 2 German regions, and compared the outcomes of standard aortic perfusion to those of aor...
متن کاملIncidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation.
Ischemic-type biliary lesions (ITBL) account for a major part of patients' morbidity and mortality after orthotopic liver transplantation (OLT). The exact origin of this type of biliary complication remains unknown. This study retrospectively evaluated 1843 patients. Patients with primary sclerosing cholangitis were excluded from this study. The diagnosis of ITBL was established only when all o...
متن کاملRisk factors for and management of ischemic-type biliary lesions following orthotopic liver transplantation: A single center experience.
INTRODUCTION Biliary complications can cause morbidity, graft loss, and mortality after liver transplantation. The most troublesome biliary complications are ischemic-type biliary lesions (ITBL), which occur since transplants can now be performed after the donor has undergone circulatory death. The exact origin of this type of biliary complication remains unknown. MATERIAL AND METHODS A total...
متن کاملIschemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation
Ischemia-reperfusion (I-R) injury after liver transplantation (LT) induces intra- and/or extrahepatic nonanastomotic ischemic-type biliary lesions (ITBLs). Subsequent bile duct stricture is a significant cause of morbidity and even mortality in patients who underwent LT. Although the pathogenesis of ITBLs is multifactorial, there are three main interconnected mechanisms responsible for their fo...
متن کامل